Race differences in obesity and its relationship to the sex hormone milieu

References

1. Van Pelt R. Etiology of the Metabolic Syndrome: Role of Visceral and Ectopic Fat. Symposium Presentation on Central vs Peripheral Adiposity in the Metabolic Syndrome. [abstract] American College of Sports Medicine National Conference; Indianapolis 2004.10.1249/00005768-200405001-00002Search in Google Scholar

2. Despres JP, Moorjani S, Ferland M, Tremblay A, Lupien PJ, Nadeau A, Pinault S, Theriault G, Bouchard C. Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis 1989;2:203–10.Search in Google Scholar

3. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994;74:761–811.10.1152/physrev.1994.74.4.761Search in Google Scholar PubMed

4. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr 1991;53:6:Suppl:1595S–603S.10.1093/ajcn/53.6.1595SSearch in Google Scholar PubMed

5. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941–8.10.1152/ajpendo.2000.278.5.E941Search in Google Scholar PubMed

6. Kohli S, Lear SA. Differences in subcutaneous abdominal adiposity regions in four ethnic groups. Obesity 2013;21:2288–95.10.1002/oby.20102Search in Google Scholar PubMed

7. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics.: a report from the American Heart Association. Circulation 2013;127:143–52.Search in Google Scholar

8. Abell JE, Egan BM, Wilson PW, Lipsitz S, Woolson RF, Lackland DT. Differences in cardiovascular disease mortality associated with body mass between Black and White persons. Am J Public Health 2008;98:63–6.10.2105/AJPH.2006.093781Search in Google Scholar PubMed PubMed Central

9. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–105.10.1056/NEJM199910073411501Search in Google Scholar PubMed

10. Perry AC, Applegate EB, Jackson ML, Deprima S, Goldberg RB, Ross R, Kempner L, Feldman BB. Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables. J Appl Physiol 2000;89:636–43.10.1152/jappl.2000.89.2.636Search in Google Scholar PubMed

11. Katzmarzyk PT, Bray GA, Greenway FL, Johnson WD, Newton RL, Jr., Ravussin E, Ryan DH, Smith SR, Bouchard C. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 2010;91:7–15.10.3945/ajcn.2009.28136Search in Google Scholar PubMed PubMed Central

12. Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Bae S, Cardarelli R. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 2008;16:600–7.10.1038/oby.2007.92Search in Google Scholar PubMed

13. Lim U, Ernst T, Buchthal SD, Latch M, Albright CL, Wilkens LR, Kolonel LN, Murphy SP, Chang L, Novotny R, Le Marchand L. Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 2011;1:e6.10.1038/nutd.2011.2Search in Google Scholar PubMed PubMed Central

14. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 2007;86:353–9.10.1093/ajcn/86.2.353Search in Google Scholar PubMed

15. Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 2007;36:220–5.10.1093/ije/dyl245Search in Google Scholar PubMed

16. Taylor HA, Jr., Coady SA, Levy D, Walker ER, Vasan RS, Liu J, Akylbekova EL, Garrison RJ, Fox C. Relationships of BMI to cardiovascular risk factors differ by ethnicity. Obesity 2010;18:1638–45.10.1038/oby.2009.407Search in Google Scholar PubMed PubMed Central

17. Schneider AL, Lazo M, Selvin E, Clark JM. Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity 2014;22:292–9.10.1002/oby.20426Search in Google Scholar PubMed PubMed Central

18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention: National Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5.10.1161/CIRCULATIONAHA.109.192644Search in Google Scholar PubMed

19. Beilby J. Definition of metabolic syndrome: report of the national heart lung, and blood institute American heart association conference on scientific issue related to definition. Circulation 2004;109:433–8.10.1161/01.CIR.0000111245.75752.C6Search in Google Scholar PubMed

20. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006;23:469–480.10.1111/j.1464-5491.2006.01858.xSearch in Google Scholar PubMed

21. Alberti KG, Zemet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis ad classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:531–53.Search in Google Scholar

22. Balestreri, CR, Caruso C, Candore G. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediat Inflamm 2010:19 pages article ID 802078, doi:10.1155/2010/802078.10.1155/2010/802078Search in Google Scholar PubMed PubMed Central

23. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994;91:4854–8.10.1073/pnas.91.11.4854Search in Google Scholar PubMed PubMed Central

24. Ho SS, Dhaliwal SS, Hills AP, Pal S. Effects of chronic exercise training on inflammatory markers in Australian overweight and obese individuals in a randomized controlled trial. Inflammation 2013;36:625–32.10.1007/s10753-012-9584-9Search in Google Scholar PubMed

25. Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 2013;9:191–200.10.5114/aoms.2013.33181Search in Google Scholar PubMed PubMed Central

26. Fantuzzi G. Systemic effects of inflammation: adipose, nutrition, and interventions. Presented at the 61st Annual Meeting of the American College of Sports Medicine, 2014.Search in Google Scholar

27. Erusan RR, Nalini D, Manohar G, Malathi R. Correlation between obesity and inflammation in cardiovascular disease- evaluation of leptin and inflammatory cytokines. Open J Endocr Met Dis 2012;2:7–15.10.4236/ojemd.2012.22002Search in Google Scholar

28. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004;15:2792–800.10.1097/01.ASN.0000141966.69934.21Search in Google Scholar PubMed

29. Ridker PM. High sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813–8.10.1161/01.CIR.103.13.1813Search in Google Scholar PubMed

30. LaMont M. C-reactive protein: biology, atherosclerosis as a risk factor and physical activity. Presented at the 51st Annual Meeting of the American College of Sports Medicine. June, 2004.Search in Google Scholar

31. Torres JL, Ridker PM. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 2003;18:471–78.10.1097/00001573-200311000-00008Search in Google Scholar PubMed

32. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006;14:Suppl 5:242S–9S.10.1038/oby.2006.317Search in Google Scholar PubMed

33. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and vitro investigations in humans. Am J Physiol Endocrinol Metab 2003;285:E527–33.10.1152/ajpendo.00110.2003Search in Google Scholar PubMed

34. Tchernof A, Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res 2000;32:526–36.10.1055/s-2007-978681Search in Google Scholar PubMed

35. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc 2006;15;295:1288–99.10.1001/jama.295.11.1288Search in Google Scholar PubMed

36. Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009;21:261–4.10.1038/ijir.2009.25Search in Google Scholar

37. Longcope C, Herbert PN, McKinlay SM, Goldfield SR. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women. J Clin Endocrinol Metab 1990;71:67–72.10.1210/jcem-71-1-67Search in Google Scholar

38. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci 2002;102:151–66.10.1042/CS20010197Search in Google Scholar

39. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab 2006;91:3697–710.10.1210/jc.2006-1121Search in Google Scholar

40. Maturana MA, Spritzer PM. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 2002;51:238–43.10.1053/meta.2002.29997Search in Google Scholar

41. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993;42:116–20.10.1016/0026-0495(93)90181-MSearch in Google Scholar

42. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996;20:291–302.Search in Google Scholar

43. Brand JS, Tweel IV, Grobbee DL, Emmelot-Vonk MT, Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analyses of observational studies. Int J Epidemiol 2011;40:189–207.10.1093/ije/dyq158Search in Google Scholar PubMed

44. Borrud LG, Flegal KM, Looker AC, Everhart JE, Harris TB, Shepherd JA. Body composition data for individuals 8 years of age and older: U.S. population, 1999–2004. Vital Health Stat 11 2010;250:1–87.Search in Google Scholar

45. Cooke PS, Naaz A. Role of estrogens in adipocyte development and function. Exp Biol Med 2004;229:1127–35.10.1177/153537020422901107Search in Google Scholar PubMed

46. Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 2014;35:8–30.10.1016/j.yfrne.2013.08.001Search in Google Scholar PubMed PubMed Central

47. Pallottini V, Bulzomi P, Galluzzo P, Martini C, Marino M. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets 2008;8:52–60.10.2174/187152608784139631Search in Google Scholar PubMed

48. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000;97:12729–34.10.1073/pnas.97.23.12729Search in Google Scholar

49. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab 2004;89:1869–78.10.1210/jc.2003-031327Search in Google Scholar

50. Naaz A, Zakroczymski M, Heine P, Taylor J, Saunders P, Lubahn D, Cooke PS. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 2002;34:758–63.10.1055/s-2002-38259Search in Google Scholar

51. Tomicek NJ, Lancaster TS, Korzick DH. Increased estrogen receptor beta in adipose tissue is associated with increased intracellular and reduced circulating adiponectin protein levels in aged female rats. Gend Med 2011;8:325–33.10.1016/j.genm.2011.05.010Search in Google Scholar

52. Rebuffe-Scrive M, Eldh J, Hafstrom LO, Bjorntorp P. Metabolism of mammary, abdominal, and femoral adipocytes in women before and after menopause. Metabolism 1986;35:792–7.10.1016/0026-0495(86)90217-9Search in Google Scholar

53. Bjorntorp P. Hormonal control of regional fat distribution. Hum Reprod 1997;12:Suppl 1:21–5.10.1093/humrep/12.suppl_1.21Search in Google Scholar PubMed

54. Perry AC, Allison M, Applegate EB, Jackson ML, Miller PC. The relationship between fat distribution and coronary risk factors in sedentary postmenopausal women on and off hormone replacement therapy. Obes Res 1998;6:40–6.10.1002/j.1550-8528.1998.tb00313.xSearch in Google Scholar PubMed

55. Munoz J, Derstine A, Gower BA. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res 2002;10:424–31.10.1038/oby.2002.59Search in Google Scholar PubMed

56. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes 2008;32:949–58.10.1038/ijo.2008.25Search in Google Scholar PubMed PubMed Central

57. Sowers M, Zheng H, Tomey K, Karvonen-Gutierrez C, Jannausch M, Li X, Yosef M, Symons J. 6-year changes in body composition in women at mid-life: ovarian and chronological aging. J Clin Endocrinol Metab 2007;92:895–901.10.1210/jc.2006-1393Search in Google Scholar PubMed PubMed Central

58. Kalme T, Loukovaara M, Koistinen R, Koistinen H, Angervo M, Leinonen P, Seppälä M. Estradiol increases the production of sex hormone-binding globulin but not insulin-like growth factor binding protein-1 in cultured human hepatoma cells. Fertil Steril 1999;72:325–9.10.1016/S0015-0282(99)00229-0Search in Google Scholar

59. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 1998;274:C1645–52.10.1152/ajpcell.1998.274.6.C1645Search in Google Scholar PubMed

60. Haffner SM, Katz MS, Stern MP, Dunn JF. Relationship of sex hormone binding globulin to overall adiposity and body fat distribution in a biethnic population. Int J Obes 1989;13:1–9.Search in Google Scholar

61. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torréns JI, SWAN Investigators. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242–9.10.1161/01.CIR.0000157697.54255.CESearch in Google Scholar PubMed

62. Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: the Study of Women’s Health Across the Nation (SWAN) fat patterning study. Obesity 2010;18:604–10.10.1038/oby.2009.251Search in Google Scholar PubMed PubMed Central

63. Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP. Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab 2001;86:97–103.10.1210/jc.86.1.97Search in Google Scholar

64. Pedersen SB, Borglum JD, Brixen K, Richelsen B. Relationship between sex hormones, body composition and metabolic risk parameters in premenopausal women. Eur J Endocrinol 1995;133:200–6.10.1530/eje.0.1330200Search in Google Scholar PubMed

65. Tchernof A, Toth MJ, Poehlman ET. Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care 1999;22:1875–81.10.2337/diacare.22.11.1875Search in Google Scholar PubMed

66. Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA. Androgens in relationship to cardiovascular risk factors in the menopausal transition. Climacteric 2008;11:509–17.10.1080/13697130802416640Search in Google Scholar PubMed

67. Phillips GB, Jing T, Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 2008;57:838–44.10.1016/j.metabol.2008.01.029Search in Google Scholar PubMed PubMed Central

68. Bell RJ, Davison SL, Papalia MA, McKenzie DP, Davis SR. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause 2007;14:630–8.10.1097/gme.0b013e31802b6cb1Search in Google Scholar

69. Haffner SM, Dunn JF, Katz MS. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992;41:278–84.10.1016/0026-0495(92)90271-BSearch in Google Scholar

70. Poretsky L, Kalin MF. The gonadotropic function of insulin. Endocr Rev 1987;8:132–41.10.1210/edrv-8-2-132Search in Google Scholar

71. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991;72:83–9.10.1210/jcem-72-1-83Search in Google Scholar

72. Perry A, Wang X, Goldberg R, Ross R, Jackson L. Androgenic sex steroids contribute to metabolic risk beyond intra-abdominal fat in overweight/obese black and white women. Obesity 2013;21:1618–24.10.1002/oby.20204Search in Google Scholar

73. Applebaum-Bowden D, McLean P, Steinmetz A, Fontana D, Matthys C, Warnick GR, Cheung M, Albers JJ, Hazzard WR. Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res 1989;30:1895–906.10.1016/S0022-2275(20)38202-XSearch in Google Scholar

74. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.10.3322/caac.20006Search in Google Scholar PubMed

75. Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV, Jr. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 2012;104:1094–101.10.1093/jnci/djs264Search in Google Scholar PubMed PubMed Central

76. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. Jr., American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25: 5287–312.10.1200/JCO.2007.14.2364Search in Google Scholar PubMed

77. Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 2013;139:539–52.10.1007/s10549-013-2560-8Search in Google Scholar PubMed PubMed Central

78. Schnitt SJ. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 2010;23:Suppl 2:S60–4.10.1038/modpathol.2010.33Search in Google Scholar PubMed

79. Chang Y, Schechter CB, van Ravesteyn NT, Near AM, Heijnsdijk EA, Adams-Campbell L, Levy D, de Koning HJ, Mandelblatt JS. Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality. Breast Cancer Res Treat 2012;136:823–35.10.1007/s10549-012-2274-3Search in Google Scholar

80. Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist 2011;16:Suppl 1:1–11.10.1634/theoncologist.2011-S1-01Search in Google Scholar

81. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005;102:13550–5.10.1073/pnas.0506230102Search in Google Scholar

82. Shen D, Wu Y, Subbarao M, Bhat H, Chillar R, Vadgama JV. Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 2000;92:29–35.Search in Google Scholar

83. Kennedy RD, Quinn JE, Johnston PG, Harkin DP. BRCA1: mechanisms of inactivation and implications for management of patients. Lancet 2002;360:1007–14.10.1016/S0140-6736(02)11087-7Search in Google Scholar

84. Rose DP, Royak-Schaler R. Tumor biology and prognosis in black breast cancer patients: a review. Cancer Detect Prev 2001;25:16–31.Search in Google Scholar

85. Agurs-Collins T, Dunn BK, Browne D, Johnson KA, Lubet R. Epidemiology of health disparities in relation to the biology of estrogen receptor-negative breast cancer. Semin Oncol 2010;37:384–401.10.1053/j.seminoncol.2010.05.002Search in Google Scholar PubMed

86. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Millikan RC. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Jama 2006;295:2492–502.10.1001/jama.295.21.2492Search in Google Scholar PubMed

87. Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705–12.10.1093/jnci/86.9.705Search in Google Scholar PubMed

88. Fisher B, Redmond C, Fisher ER, Caplan R. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node-negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 1988;6:1076–87.10.1200/JCO.1988.6.7.1076Search in Google Scholar PubMed

89. Bentzon N, Düring M, Rasmussen BB, Mouridsen H, Kroman N. Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 2008;122:1089–94.10.1002/ijc.22892Search in Google Scholar PubMed

90. Buzdar AU. Role of biologic therapy and chemotherapy in hormone receptor and HER2-positive breast cancer. Ann Oncol 2009;20:993–9.10.1093/annonc/mdn739Search in Google Scholar PubMed

91. Poola I, Clarke R, DeWitty R, Leffall LD. Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 2002;94:615–23.10.1002/cncr.10274Search in Google Scholar

92. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.10.1136/bmj.39367.495995.AESearch in Google Scholar

93. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, Hainaut P. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 2013;14:665–78.10.1111/obr.12028Search in Google Scholar

94. Rush EC, Freitas I, Plank LD. Body size, body composition and fat distribution: comparative analysis of European, Maori, Pacific Island and Asian Indian adults. Br J Nutr 2009;102:632–41.10.1017/S0007114508207221Search in Google Scholar

95. Pandey S, Pandey S, Maheshwari A, Bhattacharya S. The impact of female obesity on the outcome of fertility treatment. J Hum Reprod Sci 2010;3:62–7.10.4103/0974-1208.69332Search in Google Scholar

96. Harris HR, Willett WC, Terry KL, Michels KB. Body fat distribution and risk of premenopausal breast cancer in the Nurses’ Health Study II. J Natl Cancer Inst 2011;103:273–8.10.1093/jnci/djq500Search in Google Scholar

97. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78.10.1016/S0140-6736(08)60269-XSearch in Google Scholar

98. Cui Y, Whiteman MK, Langenberg P, Sexton M, Tkaczuk KH, Flaws JA, Bush TL. Can obesity explain the racial difference in stage of breast cancer at diagnosis between black and white women? J Womens Health Gend Based Med 2002;11:527–36.10.1089/152460902760277886Search in Google Scholar

99. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993;15:48–65.10.1093/oxfordjournals.epirev.a036116Search in Google Scholar

100. Bulun SE, Mahendroo MS, Simpson ER. Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Mol Biol 1994;49:319–26.10.1016/0960-0760(94)90274-7Search in Google Scholar

101. Harvie M, Hooper L, Howell AH. Central obesity and breast cancer risk: a systematic review. Obes Rev 2003;4:157–73.10.1046/j.1467-789X.2003.00108.xSearch in Google Scholar

102. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153–65.10.1111/j.1467-789X.2004.00142.xSearch in Google Scholar PubMed